nw/wsj/12/wsj_1228.parse 0 4 gold report-v 37.7-1 Statement report.01 1 ----- 0:2-ARG0 4:0-rel 5:2-ARG1 
nw/wsj/12/wsj_1228.parse 1 3 gold follow-v 51.6 Cotheme follow.02 4 ----- 0:1*4:1-ARG1=Theme;Cotheme 3:0-rel 5:1-ARG0=Agent;Theme 
nw/wsj/12/wsj_1228.parse 1 12 gold have-v 100 IN have.03 4 ----- 0:1*4:1-ARG0=Pivot 12:0-rel 13:2-ARG1=Theme 
nw/wsj/12/wsj_1228.parse 2 0 gold estimate-v 54.4 Estimating estimate.01 1 ----- 0:0-rel 3:0,4:1-ARG1=Theme 
nw/wsj/12/wsj_1228.parse 2 4 gold involve-v 86.2-1 NF involve.01 2 ----- 0:2-ARG2 4:0-rel 5:1-ARG1 
nw/wsj/12/wsj_1228.parse 2 7 gold omit-v 10.1 NF omit.01 1 ----- 0:3*8:1-ARG1=Theme 7:0-rel 
nw/wsj/12/wsj_1228.parse 3 3 gold compare-v 22.2-2 Evaluative_comparison compare.01 1 ----- 0:1-ARG0=Agent 3:0-rel 4:1-ARG1=Patient 6:1-ARG2=Co-Patient 
nw/wsj/12/wsj_1228.parse 3 17 gold have-v 100 IN have.03 1 ----- 7:1*12:1*25:1-ARGM-LOC 13:3-ARG0=Pivot 17:0-rel 18:1-ARG1=Theme 20:1-ARGM-TMP 7:1*12:1-LINK-SLC 
nw/wsj/12/wsj_1228.parse 4 5 gold compare-v 22.2-2 Evaluative_comparison compare.01 1 ----- 0:1-ARGM-DIS 2:1*6:1-ARG1=Patient 5:0-rel 7:1-ARG2=Co-Patient 
